GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » Advanced Medical Solutions Group PLC (LSE:AMS) » Definitions » Asset Turnover

Advanced Medical Solutions Group (LSE:AMS) Asset Turnover : 0.22 (As of Dec. 2023)


View and export this data going back to 2002. Start your Free Trial

What is Advanced Medical Solutions Group Asset Turnover?

Asset Turnover measures how quickly a company turns over its asset through sales. It is calculated as Revenue divided by Total Assets. Advanced Medical Solutions Group's Revenue for the six months ended in Dec. 2023 was £63.1 Mil. Advanced Medical Solutions Group's Total Assets for the quarter that ended in Dec. 2023 was £290.4 Mil. Therefore, Advanced Medical Solutions Group's Asset Turnover for the quarter that ended in Dec. 2023 was 0.22.

Asset Turnover is linked to ROE % through Du Pont Formula. Advanced Medical Solutions Group's annualized ROE % for the quarter that ended in Dec. 2023 was 5.71%. It is also linked to ROA % through Du Pont Formula. Advanced Medical Solutions Group's annualized ROA % for the quarter that ended in Dec. 2023 was 4.79%.


Advanced Medical Solutions Group Asset Turnover Historical Data

The historical data trend for Advanced Medical Solutions Group's Asset Turnover can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Advanced Medical Solutions Group Asset Turnover Chart

Advanced Medical Solutions Group Annual Data
Trend Dec14 Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
Asset Turnover
Get a 7-Day Free Trial Premium Member Only Premium Member Only 0.47 0.37 0.45 0.47 0.44

Advanced Medical Solutions Group Semi-Annual Data
Jun14 Dec14 Jun15 Dec15 Jun16 Dec16 Jun17 Dec17 Jun18 Dec18 Jun19 Dec19 Jun20 Dec20 Jun21 Dec21 Jun22 Dec22 Jun23 Dec23
Asset Turnover Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 0.24 0.23 0.24 0.22 0.22

Competitive Comparison of Advanced Medical Solutions Group's Asset Turnover

For the Medical Instruments & Supplies subindustry, Advanced Medical Solutions Group's Asset Turnover, along with its competitors' market caps and Asset Turnover data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Advanced Medical Solutions Group's Asset Turnover Distribution in the Medical Devices & Instruments Industry

For the Medical Devices & Instruments industry and Healthcare sector, Advanced Medical Solutions Group's Asset Turnover distribution charts can be found below:

* The bar in red indicates where Advanced Medical Solutions Group's Asset Turnover falls into.



Advanced Medical Solutions Group Asset Turnover Calculation

Asset Turnover measures how quickly a company turns over its asset through sales.

Advanced Medical Solutions Group's Asset Turnover for the fiscal year that ended in Dec. 2023 is calculated as

Asset Turnover
=Revenue/Average Total Assets
=Revenue (A: Dec. 2023 )/( (Total Assets (A: Dec. 2022 )+Total Assets (A: Dec. 2023 ))/ count )
=126.21/( (281.094+289.171)/ 2 )
=126.21/285.1325
=0.44

Advanced Medical Solutions Group's Asset Turnover for the quarter that ended in Dec. 2023 is calculated as

Asset Turnover
=Revenue/Average Total Assets
=Revenue (Q: Dec. 2023 )/( (Total Assets (Q: Jun. 2023 )+Total Assets (Q: Dec. 2023 ))/ count )
=63.122/( (291.574+289.171)/ 2 )
=63.122/290.3725
=0.22

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Companies with low profit margins tend to have high Asset Turnover, while those with high profit margins have low Asset Turnover. Companies in the retail industry tend to have a very high turnover ratio.


Advanced Medical Solutions Group  (LSE:AMS) Asset Turnover Explanation

Asset Turnover is linked to ROE % through Du Pont Formula.

Advanced Medical Solutions Group's annulized ROE % for the quarter that ended in Dec. 2023 is

ROE %**(Q: Dec. 2023 )
=Net Income/Total Stockholders Equity
=13.914/243.4775
=(Net Income / Revenue)*(Revenue / Total Assets)*(Total Assets / Total Stockholders Equity)
=(13.914 / 126.244)*(126.244 / 290.3725)*(290.3725/ 243.4775)
=Net Margin %*Asset Turnover*Equity Multiplier
=11.02 %*0.4348*1.1926
=ROA %*Equity Multiplier
=4.79 %*1.1926
=5.71 %

Note: The Net Income data used here is two times the semi-annual (Dec. 2023) net income data. The Revenue data used here is two times the semi-annual (Dec. 2023) revenue data.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

** The ROE % used above is for Du Pont Analysis only. It is different from the defined ROE % page on our website, as here it uses Net Income instead of Net Income attributable to Common Stockholders in the calculation.

It is also linked to ROA % through Du Pont Formula:

Advanced Medical Solutions Group's annulized ROA % for the quarter that ended in Dec. 2023 is

ROA %(Q: Dec. 2023 )
=Net Income/Total Assets
=13.914/290.3725
=(Net Income / Revenue)*(Revenue / Total Assets)
=(13.914 / 126.244)*(126.244 / 290.3725)
=Net Margin %*Asset Turnover
=11.02 %*0.4348
=4.79 %

Note: The Net Income data used here is two times the semi-annual (Dec. 2023) net income data. The Revenue data used here is two times the semi-annual (Dec. 2023) revenue data.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Be Aware

In the article Joining The Dark Side: Pirates, Spies and Short Sellers, James Montier reported that In their US sample covering the period 1968-2003, Cooper et al find that firms with low asset growth outperformed firms with high asset growth by an astounding 20% p.a. equally weighted. Even when controlling for market, size and style, low asset growth firms outperformed high asset growth firms by 13% p.a. Therefore a company with fast asset growth may underperform.

Therefore, it is a good sign if a company's Asset Turnover is consistent or even increases. If a company's asset grows faster than sales, its Asset Turnover will decline, which can be a warning sign.


Advanced Medical Solutions Group Asset Turnover Related Terms

Thank you for viewing the detailed overview of Advanced Medical Solutions Group's Asset Turnover provided by GuruFocus.com. Please click on the following links to see related term pages.


Advanced Medical Solutions Group (LSE:AMS) Business Description

Traded in Other Exchanges
Address
Premier Park, 33 Road One, Winsford Industrial Estate, Winsford, Cheshire, GBR, CW7 3RT
U.K.-based Advanced Medical Solutions was founded in 1991 to design, develop, and manufacture advanced wound-care products for other healthcare manufacturers. AMS' key branded products include the ActivHeal franchise of hydrogel, hydrocolloid, foam, and alginate wound dressings. The firm also manufactures and markets a suite of branded products in surgical use, including the LiquiBand franchise for tissue adhesion and the Resorba line of sutures and collagen-based products for tissue repair. The firm derives approximately 60% of total revenue from branded products, with nonbranded contributing 40%.